The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study

    March 2022 in “ Frontiers in Endocrinology ”
    Mahbanoo Farhadi-Azar, Samira Behboudi‐Gandevani, Maryam Rahmati, Fatemeh Mahboobifard, Ensi Khalili Pouya, Fahimeh Ramezani Tehrani, Fereidoun Azizi
    Image of study
    TLDR About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.
    The study, which included 1,960 Iranian women, found that Polycystic Ovary Syndrome (PCOS) is prevalent in 19.4% of the participants. The most common phenotype was phenotype B, characterized by oligo/anovulatory dysfunction and hyperandrogenism. Women with PCOS had higher serum levels of total testosterone, androstenedione, DHEAS, and free androgen index compared to healthy women. However, there were no significant differences in BMI, WC, HC, WHR, WHtR, and ABSI between PCOS and healthy subjects after adjusting for age and BMI. The cardio-metabolic profile of women with PCOS was similar to healthy women. The study suggests that routine screening for metabolic disturbances may be needed in the prevention of cardio-metabolic disorders in patients with more serious phenotypes of PCOS.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 21 results

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 6 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    4 / 4 results